Compare DSP Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.95
2.28
NAV
₹36.92
₹276.65
Fund Started
12 Nov 2018
01 Aug 2005
Fund Size
₹3033.42 Cr
₹1106.71 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 30 days.
1 Year
1.61%
8.27%
3 Year
21.24%
25.23%
5 Year
13.98%
14.88%
Equity
97.91%
98.21%
Cash
2.09%
1.79%
Top 10 Holdings
Ipca Laboratories Ltd. | 8.40% |
Sun Pharmaceutical Industries Ltd. | 8.25% |
Cipla Ltd. | 8.08% |
Globus Medical Inc | 7.54% |
Illumina Inc. (USA) | 7.18% |
Laurus Labs Ltd. | 5.95% |
Gland Pharma Ltd. | 5.72% |
Sai Life Sciences Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.56% |
Cohance Lifesciences Ltd. | 3.81% |
Sun Pharmaceutical Industries Ltd. | 9.42% |
Ajanta Pharma Ltd. | 7.04% |
Lupin Ltd. | 5.79% |
Glenmark Pharmaceuticals Ltd. | 4.25% |
Apollo Hospitals Enterprise Ltd. | 3.75% |
Gland Pharma Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.52% |
Dr. Reddy's Laboratories Ltd. | 3.48% |
Alkem Laboratories Ltd. | 3.47% |
Fortis Healthcare Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
12 Nov 2018
01 Aug 2005
